Alpha Teknova (TKNO): Investors are Waiting for Leading Indicators to Drive Sales

4 weeks ago 17

Soumya Eswaran

Fri, February 20, 2026 astatine 7:24 AM CST 3 min read

Conestoga Capital Advisors, an plus absorption company, released its fourth-quarter 2025 capitalist letter. US equities experienced coagulated returns successful 2025, with double-digit gains crossed each large indices. A transcript of the missive tin beryllium downloaded here. In 2025, the Conestoga Micro Cap Composite met its intent of preserving superior during antagonistic marketplace returns and capturing upside during beardown marketplace returns. Micro Caps faced important volatility successful 2025. During the people of events, Conestoga Micro Cap Composite returned -1.91% nett of fees successful the 4th fourth and 16.24% nett of fees for the afloat twelvemonth 2025, trailing the Russell Microcap Growth Index’s 2.14% and 21.84% gains successful the 4th fourth and afloat year, respectively. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Conestoga Capital Advisors highlighted stocks similar Alpha Teknova, Inc. (NASDAQ:TKNO). Alpha Teknova, Inc. (NASDAQ:TKNO) is simply a biotechnology institution that provides captious reagents for the discovery, development, and commercialization of caller therapies. On February 19, 2026, Alpha Teknova, Inc. (NASDAQ:TKNO) banal closed astatine $2.09 per share. One-month instrumentality of Alpha Teknova, Inc. (NASDAQ:TKNO) was -37.05%, and its shares mislaid 71.95% implicit the past 52 weeks. Alpha Teknova, Inc. (NASDAQ:TKNO) has a marketplace capitalization of $111.876 million.

Conestoga Capital Advisors stated the pursuing regarding Alpha Teknova, Inc. (NASDAQ:TKNO) successful its 4th fourth 2025 capitalist letter:

"Alpha Teknova, Inc. (NASDAQ:TKNO) is simply a starring supplier of captious reagents that alteration the discovery, development, and accumulation of biopharmaceutical products specified arsenic cause therapies, caller vaccines, and molecular diagnostics. The institution reported a coagulated 4th and pointed to affirmative starring indicators successful extremity markets driven by biotech backing and bully maturation with ample pharma companies. That said, the affirmative starring indicators person not yet translated into sales, and investors proceed with a "wait-and-see" attack to a betterment successful early-stage biotech funding."

Alpha Teknova, Inc. (NASDAQ:TKNO) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 12 hedge money portfolios held Alpha Teknova, Inc. (NASDAQ:TKNO) astatine the extremity of the 3rd quarter, up from 11 successful the erstwhile quarter. While we admit the imaginable of Alpha Teknova, Inc. (NASDAQ:TKNO) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article